Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

1685 reported adverse events

Drugs of this class: ALGLUCOSIDASE ALFA AVALGLUCOSIDASE ALFA

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] class:

# Side effect Count
0 DYSPNOEA 113
1 PYREXIA 110
2 MALAISE 83
3 URTICARIA 79
4 OFF LABEL USE 77
5 INFUSION RELATED REACTION 70
6 RASH 68
7 PNEUMONIA 67
8 FALL 66
9 FATIGUE 66
See all common reactions for Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY HEXOSE TETRASACCHARIDE INCREASED 4 0.8000
1 NEUTRALISING ANTIBODIES NEGATIVE 4 0.1429
2 DRUG SPECIFIC ANTIBODY ABSENT 19 0.1397
3 COMPLEMENT FIXATION TEST POSITIVE 1 0.1111
4 ELECTROCARDIOGRAM PACEMAKER SPIKE 1 0.1111
5 DYSMYELINATION 1 0.0909
6 EAR TUBE REMOVAL 1 0.0833
7 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 4 0.0755
8 TRACHEOSTOMY TUBE REMOVAL 2 0.0741
9 WINGED SCAPULA 2 0.0714
See all enriched reactions for Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]